Evaluate Safety of Axicabtagene Ciloleucel Reinfusion (Axi-Cel-2) in Patients With Relapsed and/or Refractory Second Line High-Risk Non-Hodgkin Lymphoma After Standard of Care Axi-Cel
for
Non-Hodgkin Lymphoma, Large B-cell Lymphoma
Location: Palo Alto CA
Sponsor: Stanford University
Sex: All
Age: 18+
Code: NCT05794958
Phase1, Recruiting
CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT
for
Acute Leukemia, Acute Myeloid Leukemia,
Location: Philadelphia PA
Sponsor: Children's Hospital of Philadelphia
Sex: All
Age: 0 - 25
Code: NCT03810196
Recruiting
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
for
Mantle Cell Lymphoma, B Cell Lymphoma
Location: Boston MA, New Haven CT, New York NY, Paramus NJ,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06742996
Phase3, Recruiting
CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies
for
B-Cell Leukemia, Non-Hodgkin's Lymphoma,
Location: Ottawa, Toronto, Calgary, Vancouver
Sponsor: British Columbia Cancer Agency
Sex: All
Age: 1+
Code: NCT06208735
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now